QuidelOrtho
QDEL
$39.42
Share price
-3.44%
Change (1 day)
-57.44%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - P/B ratio
P/B ratio as of April 2024 : 0.5454
According to QuidelOrtho's latest financial reports the company has a price-to-book ratio of 0.5454.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
QuidelOrtho - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9837 | -14.2% |
| 2022-12-31 | 1.15 | -60.69% |
| 2021-12-31 | 2.92 | -48.57% |
| 2020-12-31 | 5.67 | 1.06% |
| 2019-12-31 | 5.61 | 24.2% |
| 2018-12-31 | 4.52 | -30.38% |
| 2017-12-31 | 6.49 | 86.2% |
| 2016-12-31 | 3.49 | 7.88% |
| 2015-12-31 | 3.23 | -20.51% |
| 2014-12-31 | 4.06 | -13.59% |
| 2013-12-31 | 4.70 | 50.45% |
| 2012-12-31 | 3.13 | 15.2% |
| 2011-12-31 | 2.71 | -25.89% |
| 2010-12-31 | 3.66 | 15.76% |
| 2009-12-31 | 3.16 | -11.34% |
| 2008-12-31 | 3.57 | -39.66% |
| 2007-12-31 | 5.91 | 33.71% |
| 2006-12-31 | 4.42 | 5.75% |
| 2005-12-31 | 4.18 | 133.08% |
| 2004-12-31 | 1.79 | -50.82% |
| 2003-12-31 | 3.65 | 128.41% |
| 2002-12-31 | 1.60 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.71 | 762.77% | 🇺🇸 USA |
 Becton Dickinson BDX | 2.67 | 388.97% | 🇺🇸 USA |
 Danaher DHR | 3.47 | 535.82% | 🇺🇸 USA |
 PerkinElmer
PKI | 1.80 | 229.95% | 🇺🇸 USA |
 OraSure Technologies OSUR | 0.9771 | 79.17% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 4.05 | 641.73% | 🇺🇸 USA |